Change language to: Deutsch  
 
German Cancer Research Center

Prof. Dr. Kari Hemminki

Bild der Person
Bezeichung Inhalt
Position: Head
Phone: +49.62 21.42-18 00
Fax: +49.62 21.42-18 10
E-mail: Contact Form
Building TP 3
Room B3.211


Education

1973 PhD in Medicine, University of Helsinki, Finland
1973 MD in Medicine, University of Helsinki, Finland
1975 Docent in Biochemistry, University of Helsinki, Finland
1976 - 1978 Postdoc in Molecular Biology, John Hopkins, Baltimore, USA

Research field

diabetes, cancer, liver cancer, prostate cancer, leukemia, risk factors, Polycythemia vera, myelofibrosis, family history

Selected publications

Lorenzo Bermejo J, Hemminki K. Familial risk of cancer shortly after diagnosis of the first familial tumor. J Natl Cancer Inst 2005;97:575-9.

Lorenzo Bermejo L, Eng C, Hemminki K. Cancer characteristics in Swedish families fulfilling criteria for hereditary non-polyposis colorectal cancer. Gastroenterology 2005;129:1889-99.

Maule M, Scelo G, Merletti F, Brennan P, Hemminki K, Tracey E, Sankila R, Weiderpass Vainio E, Olsen J, McBride M, Brewster D, Pompe-Kirn V, Kliewer E, Chia KS, Tonita J, Martos C, Jonasson J, Pastore G, Boffetta P. Risk of second malignant neoplasms after childhood leukemia and lymphoma: An international study. J Natl Cancer Inst. 2007;99:790-800.

Anderson LA, Pfeiffer RM, Rapkin JS, Gridley G, Mellemkjaer L, Hemminki K, Björkholm M, Goldin LR, Caporaso NR, Landgren O. Survival patterns among lymphoma patients with a family history of lymphoma. J Clin Oncol. 2008;26:4958-65.

Hemminki K, Ji J, Försti A, Sundquist J, Lenner P. Concordance of survival in family members with prostate cancer. J Clin Oncol. 2008 26:1705-9.

Hemminki K, Lenner P, Sundquist J, Lorenzo Bermejo J. Risk of subsequent solid tumors after non-Hodgkin lymphoma: effect of diagnostic age and time since diagnosis. J Clin Oncol. 2008;26:1850-7.

Hemminki K, Tretli S, Sundquist J, Johannesen TB, Granström C. Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway. Lancet Oncol. 2009;10:481-8.

 

Print
   Last Update:
24/09/2009